对于心力衰竭患者的电子健康自我管理干预措施的比较有效性:贝叶斯网络元分析
Dan Li1, Le-Tian Huang2, Fei Zhang1
1Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, PR China.
Patient education and counseling
|April 13, 2024
概括
电子自我管理干预措施,包括监控和提醒,可以改善心力衰竭患者的结果. 这些数字工具有助于降低死亡率和再接收率,提高生活质量.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心力衰竭 (HF) 构成了全球严重的健康负担.
- 有效的管理策略对于改善患者的预后和生活质量至关重要.
- 电子干预为增强患者自我管理提供了一个有希望的途径.
研究的目的:
- 评估心力衰竭患者电子自我管理支持干预措施的有效性.
- 评估对所有原因死亡率,心血管死亡率和再接收率的影响.
- 确定与改善结果相关的特定干预类型 (监测,提醒,混合).
主要方法:
- 随机对照试验 (RCT) 和电子卫生技术试验的系统审查和元分析.
- 在PubMed,Cochrane图书馆和Embase中按照PRISMA-P指南进行的搜索.
- 使用Cochrane ROB2工具评估的偏差风险.
主要成果:
- 监测干预措施显示,所有原因死亡率 (OR 0.77) 和心血管死亡率 (OR 0.75) 的潜在降低.
- 提醒干预措施显著降低了整体再接收率 (OR 0.07).
- 混合干预最有效地减少了与心力衰竭相关的再入院 (OR 0.75).
结论:
- 电子自我管理干预措施,特别是监测和提醒,可以改善心力衰竭患者的结果.
- 这些数字健康工具显示出降低死亡率和再接收率的潜力.
- 电子健康模型与自我管理相结合,对于长期高风患者的护理和预后至关重要.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:30Stress Prevention and Stress Management Techniques VI
31
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
31